nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—NR3C1—epilepsy syndrome	0.656	1	CbGaD
Amcinonide—Atrophy—Vigabatrin—epilepsy syndrome	0.00612	0.0559	CcSEcCtD
Amcinonide—Miliaria—Oxcarbazepine—epilepsy syndrome	0.00603	0.055	CcSEcCtD
Amcinonide—Hypertrichosis—Phenytoin—epilepsy syndrome	0.00469	0.0428	CcSEcCtD
Amcinonide—Miliaria—Pregabalin—epilepsy syndrome	0.00402	0.0367	CcSEcCtD
Amcinonide—Skin atrophy—Pregabalin—epilepsy syndrome	0.00391	0.0357	CcSEcCtD
Amcinonide—Leukoderma—Lamotrigine—epilepsy syndrome	0.00387	0.0353	CcSEcCtD
Amcinonide—ANXA1—forebrain—epilepsy syndrome	0.00368	0.102	CbGeAlD
Amcinonide—ANXA1—telencephalon—epilepsy syndrome	0.00338	0.0942	CbGeAlD
Amcinonide—Folliculitis—Oxcarbazepine—epilepsy syndrome	0.00282	0.0257	CcSEcCtD
Amcinonide—Stinging—Propofol—epilepsy syndrome	0.00271	0.0247	CcSEcCtD
Amcinonide—Rash pustular—Levetiracetam—epilepsy syndrome	0.00266	0.0243	CcSEcCtD
Amcinonide—ANXA1—medulla oblongata—epilepsy syndrome	0.00266	0.074	CbGeAlD
Amcinonide—Rash pustular—Fosphenytoin—epilepsy syndrome	0.00257	0.0234	CcSEcCtD
Amcinonide—Tenderness—Midazolam—epilepsy syndrome	0.00246	0.0225	CcSEcCtD
Amcinonide—ANXA1—midbrain—epilepsy syndrome	0.00243	0.0677	CbGeAlD
Amcinonide—Hypertrichosis—Topiramate—epilepsy syndrome	0.0024	0.0219	CcSEcCtD
Amcinonide—ANXA1—spinal cord—epilepsy syndrome	0.00237	0.066	CbGeAlD
Amcinonide—Rash pustular—Zonisamide—epilepsy syndrome	0.00233	0.0213	CcSEcCtD
Amcinonide—NR3C1—hindbrain—epilepsy syndrome	0.00231	0.0643	CbGeAlD
Amcinonide—Tenderness—Diazepam—epilepsy syndrome	0.00225	0.0205	CcSEcCtD
Amcinonide—Rash pustular—Phenytoin—epilepsy syndrome	0.00223	0.0204	CcSEcCtD
Amcinonide—ANXA1—head—epilepsy syndrome	0.00211	0.0587	CbGeAlD
Amcinonide—Rash pustular—Lamotrigine—epilepsy syndrome	0.00206	0.0188	CcSEcCtD
Amcinonide—Tenderness—Phenytoin—epilepsy syndrome	0.00204	0.0186	CcSEcCtD
Amcinonide—Dermatitis contact—Fosphenytoin—epilepsy syndrome	0.00202	0.0185	CcSEcCtD
Amcinonide—ANXA1—nervous system—epilepsy syndrome	0.002	0.0556	CbGeAlD
Amcinonide—ANXA1—central nervous system—epilepsy syndrome	0.00192	0.0536	CbGeAlD
Amcinonide—ANXA1—cerebellum—epilepsy syndrome	0.00188	0.0523	CbGeAlD
Amcinonide—Dermatitis contact—Clonazepam—epilepsy syndrome	0.00177	0.0162	CcSEcCtD
Amcinonide—Dermatitis contact—Phenytoin—epilepsy syndrome	0.00176	0.0161	CcSEcCtD
Amcinonide—Dermatitis contact—Oxcarbazepine—epilepsy syndrome	0.00175	0.016	CcSEcCtD
Amcinonide—Rash pustular—Valproic Acid—epilepsy syndrome	0.00164	0.0149	CcSEcCtD
Amcinonide—Dermatitis contact—Lamotrigine—epilepsy syndrome	0.00162	0.0148	CcSEcCtD
Amcinonide—ANXA1—brain—epilepsy syndrome	0.00153	0.0425	CbGeAlD
Amcinonide—Rash pustular—Pregabalin—epilepsy syndrome	0.00148	0.0135	CcSEcCtD
Amcinonide—Rash pustular—Gabapentin—epilepsy syndrome	0.00136	0.0124	CcSEcCtD
Amcinonide—NR3C1—brainstem—epilepsy syndrome	0.00132	0.0369	CbGeAlD
Amcinonide—NR3C1—forebrain—epilepsy syndrome	0.00128	0.0356	CbGeAlD
Amcinonide—NR3C1—telencephalon—epilepsy syndrome	0.00118	0.0327	CbGeAlD
Amcinonide—Infection—Rufinamide—epilepsy syndrome	0.00103	0.00941	CcSEcCtD
Amcinonide—Infection—Clobazam—epilepsy syndrome	0.00094	0.00858	CcSEcCtD
Amcinonide—NR3C1—medulla oblongata—epilepsy syndrome	0.000923	0.0257	CbGeAlD
Amcinonide—Pain—Phenobarbital—epilepsy syndrome	0.000904	0.00825	CcSEcCtD
Amcinonide—Dermatitis—Amobarbital—epilepsy syndrome	0.000887	0.0081	CcSEcCtD
Amcinonide—Dermatitis—Primidone—epilepsy syndrome	0.000855	0.00781	CcSEcCtD
Amcinonide—Pruritus—Trimethadione—epilepsy syndrome	0.000845	0.00771	CcSEcCtD
Amcinonide—NR3C1—midbrain—epilepsy syndrome	0.000844	0.0235	CbGeAlD
Amcinonide—NR3C1—spinal cord—epilepsy syndrome	0.000823	0.0229	CbGeAlD
Amcinonide—Dermatitis—Trimethadione—epilepsy syndrome	0.000752	0.00687	CcSEcCtD
Amcinonide—Infection—Levetiracetam—epilepsy syndrome	0.000752	0.00686	CcSEcCtD
Amcinonide—Pruritus—Rufinamide—epilepsy syndrome	0.000734	0.0067	CcSEcCtD
Amcinonide—NR3C1—head—epilepsy syndrome	0.000732	0.0204	CbGeAlD
Amcinonide—Infection—Fosphenytoin—epilepsy syndrome	0.000725	0.00662	CcSEcCtD
Amcinonide—Infection—Vigabatrin—epilepsy syndrome	0.000707	0.00646	CcSEcCtD
Amcinonide—Infection—Diazepam—epilepsy syndrome	0.000696	0.00635	CcSEcCtD
Amcinonide—NR3C1—nervous system—epilepsy syndrome	0.000694	0.0193	CbGeAlD
Amcinonide—Pruritus—Lacosamide—epilepsy syndrome	0.000689	0.00629	CcSEcCtD
Amcinonide—Infection—Felbamate—epilepsy syndrome	0.000674	0.00615	CcSEcCtD
Amcinonide—Pain—Propofol—epilepsy syndrome	0.00067	0.00611	CcSEcCtD
Amcinonide—Pruritus—Clobazam—epilepsy syndrome	0.000669	0.00611	CcSEcCtD
Amcinonide—NR3C1—central nervous system—epilepsy syndrome	0.000668	0.0186	CbGeAlD
Amcinonide—Dermatitis—Phenobarbital—epilepsy syndrome	0.000666	0.00608	CcSEcCtD
Amcinonide—Infection—Zonisamide—epilepsy syndrome	0.000659	0.00602	CcSEcCtD
Amcinonide—Pain—Midazolam—epilepsy syndrome	0.000655	0.00598	CcSEcCtD
Amcinonide—Dermatitis—Rufinamide—epilepsy syndrome	0.000654	0.00597	CcSEcCtD
Amcinonide—NR3C1—cerebellum—epilepsy syndrome	0.000653	0.0182	CbGeAlD
Amcinonide—Pain—Levetiracetam—epilepsy syndrome	0.000647	0.00591	CcSEcCtD
Amcinonide—Infection—Clonazepam—epilepsy syndrome	0.000636	0.0058	CcSEcCtD
Amcinonide—Infection—Phenytoin—epilepsy syndrome	0.000631	0.00576	CcSEcCtD
Amcinonide—Infection—Oxcarbazepine—epilepsy syndrome	0.000628	0.00573	CcSEcCtD
Amcinonide—Dermatitis—Lacosamide—epilepsy syndrome	0.000614	0.0056	CcSEcCtD
Amcinonide—Pain—Vigabatrin—epilepsy syndrome	0.000609	0.00556	CcSEcCtD
Amcinonide—Infection—Carbamazepine—epilepsy syndrome	0.000603	0.0055	CcSEcCtD
Amcinonide—Pain—Diazepam—epilepsy syndrome	0.000599	0.00547	CcSEcCtD
Amcinonide—Dermatitis—Clobazam—epilepsy syndrome	0.000596	0.00544	CcSEcCtD
Amcinonide—Infection—Lamotrigine—epilepsy syndrome	0.000582	0.00532	CcSEcCtD
Amcinonide—Pain—Felbamate—epilepsy syndrome	0.00058	0.00529	CcSEcCtD
Amcinonide—Pruritus—Propofol—epilepsy syndrome	0.000554	0.00506	CcSEcCtD
Amcinonide—Pain—Clonazepam—epilepsy syndrome	0.000547	0.00499	CcSEcCtD
Amcinonide—Pruritus—Midazolam—epilepsy syndrome	0.000542	0.00495	CcSEcCtD
Amcinonide—Pain—Oxcarbazepine—epilepsy syndrome	0.000541	0.00493	CcSEcCtD
Amcinonide—Pruritus—Levetiracetam—epilepsy syndrome	0.000535	0.00489	CcSEcCtD
Amcinonide—NR3C1—brain—epilepsy syndrome	0.00053	0.0148	CbGeAlD
Amcinonide—Pain—Carbamazepine—epilepsy syndrome	0.000519	0.00474	CcSEcCtD
Amcinonide—Pruritus—Fosphenytoin—epilepsy syndrome	0.000517	0.00472	CcSEcCtD
Amcinonide—Pruritus—Vigabatrin—epilepsy syndrome	0.000504	0.0046	CcSEcCtD
Amcinonide—Pain—Lamotrigine—epilepsy syndrome	0.000501	0.00458	CcSEcCtD
Amcinonide—Pruritus—Diazepam—epilepsy syndrome	0.000496	0.00453	CcSEcCtD
Amcinonide—Dermatitis—Propofol—epilepsy syndrome	0.000493	0.0045	CcSEcCtD
Amcinonide—Dermatitis—Midazolam—epilepsy syndrome	0.000483	0.00441	CcSEcCtD
Amcinonide—Pruritus—Felbamate—epilepsy syndrome	0.00048	0.00438	CcSEcCtD
Amcinonide—Dermatitis—Levetiracetam—epilepsy syndrome	0.000477	0.00435	CcSEcCtD
Amcinonide—Pruritus—Zonisamide—epilepsy syndrome	0.00047	0.00429	CcSEcCtD
Amcinonide—Infection—Valproic Acid—epilepsy syndrome	0.000463	0.00423	CcSEcCtD
Amcinonide—Dermatitis—Fosphenytoin—epilepsy syndrome	0.00046	0.0042	CcSEcCtD
Amcinonide—Pruritus—Clonazepam—epilepsy syndrome	0.000453	0.00413	CcSEcCtD
Amcinonide—Pruritus—Phenytoin—epilepsy syndrome	0.00045	0.0041	CcSEcCtD
Amcinonide—Dermatitis—Vigabatrin—epilepsy syndrome	0.000448	0.00409	CcSEcCtD
Amcinonide—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000447	0.00408	CcSEcCtD
Amcinonide—Dermatitis—Diazepam—epilepsy syndrome	0.000441	0.00403	CcSEcCtD
Amcinonide—Pruritus—Carbamazepine—epilepsy syndrome	0.000429	0.00392	CcSEcCtD
Amcinonide—Dermatitis—Felbamate—epilepsy syndrome	0.000427	0.0039	CcSEcCtD
Amcinonide—Infection—Pregabalin—epilepsy syndrome	0.000418	0.00382	CcSEcCtD
Amcinonide—Dermatitis—Zonisamide—epilepsy syndrome	0.000418	0.00382	CcSEcCtD
Amcinonide—Pruritus—Lamotrigine—epilepsy syndrome	0.000415	0.00379	CcSEcCtD
Amcinonide—Dermatitis—Clonazepam—epilepsy syndrome	0.000403	0.00368	CcSEcCtD
Amcinonide—Dermatitis—Phenytoin—epilepsy syndrome	0.0004	0.00365	CcSEcCtD
Amcinonide—Pain—Valproic Acid—epilepsy syndrome	0.000398	0.00364	CcSEcCtD
Amcinonide—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000398	0.00364	CcSEcCtD
Amcinonide—Prednisone—SLCO1A2—epilepsy syndrome	0.000397	0.0431	CrCbGaD
Amcinonide—Infection—Gabapentin—epilepsy syndrome	0.000384	0.0035	CcSEcCtD
Amcinonide—Dermatitis—Carbamazepine—epilepsy syndrome	0.000382	0.00349	CcSEcCtD
Amcinonide—Dermatitis—Lamotrigine—epilepsy syndrome	0.000369	0.00337	CcSEcCtD
Amcinonide—Prednisolone—SLCO1A2—epilepsy syndrome	0.000366	0.0397	CrCbGaD
Amcinonide—Pain—Pregabalin—epilepsy syndrome	0.00036	0.00329	CcSEcCtD
Amcinonide—Difluprednate—NR3C1—epilepsy syndrome	0.000343	0.0373	CrCbGaD
Amcinonide—Prednicarbate—NR3C1—epilepsy syndrome	0.000333	0.0362	CrCbGaD
Amcinonide—Pain—Gabapentin—epilepsy syndrome	0.00033	0.00301	CcSEcCtD
Amcinonide—Pruritus—Valproic Acid—epilepsy syndrome	0.00033	0.00301	CcSEcCtD
Amcinonide—Infection—Topiramate—epilepsy syndrome	0.000323	0.00295	CcSEcCtD
Amcinonide—Diflorasone—NR3C1—epilepsy syndrome	0.000315	0.0342	CrCbGaD
Amcinonide—Desonide—NR3C1—epilepsy syndrome	0.000315	0.0342	CrCbGaD
Amcinonide—Desoximetasone—NR3C1—epilepsy syndrome	0.000307	0.0334	CrCbGaD
Amcinonide—Loteprednol—NR3C1—epilepsy syndrome	0.000303	0.033	CrCbGaD
Amcinonide—Pruritus—Pregabalin—epilepsy syndrome	0.000298	0.00272	CcSEcCtD
Amcinonide—Dermatitis—Valproic Acid—epilepsy syndrome	0.000293	0.00268	CcSEcCtD
Amcinonide—Pain—Topiramate—epilepsy syndrome	0.000278	0.00254	CcSEcCtD
Amcinonide—Pruritus—Gabapentin—epilepsy syndrome	0.000273	0.00249	CcSEcCtD
Amcinonide—Flurandrenolide—NR3C1—epilepsy syndrome	0.000269	0.0292	CrCbGaD
Amcinonide—Dermatitis—Pregabalin—epilepsy syndrome	0.000265	0.00242	CcSEcCtD
Amcinonide—Flumethasone Pivalate—NR3C1—epilepsy syndrome	0.000264	0.0287	CrCbGaD
Amcinonide—Halobetasol Propionate—NR3C1—epilepsy syndrome	0.00026	0.0283	CrCbGaD
Amcinonide—Cortisone acetate—NR3C1—epilepsy syndrome	0.000256	0.0278	CrCbGaD
Amcinonide—Dermatitis—Gabapentin—epilepsy syndrome	0.000243	0.00222	CcSEcCtD
Amcinonide—Budesonide—NR3C1—epilepsy syndrome	0.000242	0.0263	CrCbGaD
Amcinonide—Fluticasone furoate—NR3C1—epilepsy syndrome	0.000237	0.0258	CrCbGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	0.000235	0.00124	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	0.000234	0.00124	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PDYN—epilepsy syndrome	0.000234	0.00124	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CHRM1—epilepsy syndrome	0.000234	0.00124	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GRM1—epilepsy syndrome	0.000234	0.00124	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCR7—epilepsy syndrome	0.000234	0.00124	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GRM8—epilepsy syndrome	0.000232	0.00123	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	0.000231	0.00122	CbGpPWpGaD
Amcinonide—Mometasone—NR3C1—epilepsy syndrome	0.00023	0.025	CrCbGaD
Amcinonide—Pruritus—Topiramate—epilepsy syndrome	0.00023	0.0021	CcSEcCtD
Amcinonide—Rimexolone—NR3C1—epilepsy syndrome	0.000227	0.0247	CrCbGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	0.000227	0.0012	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—epilepsy syndrome	0.000226	0.0012	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	0.000225	0.00119	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ACKR4—epilepsy syndrome	0.000224	0.00119	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—POMC—epilepsy syndrome	0.000222	0.00117	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—OPRD1—epilepsy syndrome	0.000221	0.00117	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GNAO1—epilepsy syndrome	0.000221	0.00117	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	0.000221	0.00117	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GAL—epilepsy syndrome	0.00022	0.00116	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	0.00022	0.00116	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—AGT—epilepsy syndrome	0.000219	0.00116	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—PLAU—epilepsy syndrome	0.000218	0.00115	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CHRM3—epilepsy syndrome	0.000217	0.00115	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GRM5—epilepsy syndrome	0.000217	0.00115	CbGpPWpGaD
Amcinonide—Beclomethasone—NR3C1—epilepsy syndrome	0.000214	0.0233	CrCbGaD
Amcinonide—Fluocinonide—NR3C1—epilepsy syndrome	0.000214	0.0233	CrCbGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	0.000213	0.00113	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PDYN—epilepsy syndrome	0.000212	0.00112	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GRM1—epilepsy syndrome	0.000212	0.00112	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CHRM1—epilepsy syndrome	0.000212	0.00112	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCR7—epilepsy syndrome	0.000212	0.00112	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	0.000209	0.00111	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	0.000209	0.0011	CbGpPWpGaD
Amcinonide—Fluocinolone Acetonide—NR3C1—epilepsy syndrome	0.000208	0.0227	CrCbGaD
Amcinonide—Dexamethasone—SLCO1A2—epilepsy syndrome	0.000208	0.0226	CrCbGaD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—epilepsy syndrome	0.000207	0.0011	CbGpPWpGaD
Amcinonide—Dermatitis—Topiramate—epilepsy syndrome	0.000205	0.00187	CcSEcCtD
Amcinonide—ANXA1—GPCR downstream signaling—CHRM2—epilepsy syndrome	0.000204	0.00108	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	0.000204	0.00108	CbGpPWpGaD
Amcinonide—Clobetasol propionate—NR3C1—epilepsy syndrome	0.000203	0.0221	CrCbGaD
Amcinonide—Fludrocortisone—NR3C1—epilepsy syndrome	0.000203	0.0221	CrCbGaD
Amcinonide—Flunisolide—NR3C1—epilepsy syndrome	0.000203	0.0221	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—SSTR5—epilepsy syndrome	0.000203	0.00107	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SSTR4—epilepsy syndrome	0.000203	0.00107	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—AVP—epilepsy syndrome	0.000202	0.00107	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GAL—epilepsy syndrome	0.0002	0.00106	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GABBR1—epilepsy syndrome	0.000199	0.00105	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	0.000198	0.00105	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	0.000198	0.00105	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CHRM3—epilepsy syndrome	0.000197	0.00104	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GRM5—epilepsy syndrome	0.000197	0.00104	CbGpPWpGaD
Amcinonide—Ciclesonide—NR3C1—epilepsy syndrome	0.000197	0.0214	CrCbGaD
Amcinonide—Triamcinolone—BCHE—epilepsy syndrome	0.000196	0.0213	CrCbGaD
Amcinonide—Fluorometholone—NR3C1—epilepsy syndrome	0.000196	0.0213	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—CCR10—epilepsy syndrome	0.000195	0.00103	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	0.000194	0.00103	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—SST—epilepsy syndrome	0.000193	0.00102	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	0.000193	0.00102	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	0.000192	0.00102	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HRH3—epilepsy syndrome	0.000191	0.00101	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.000189	0.001	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	0.000188	0.000996	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.000188	0.000993	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.000185	0.000982	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CHRM2—epilepsy syndrome	0.000185	0.000982	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.000185	0.000982	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—FOS—epilepsy syndrome	0.000185	0.000979	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP11A1—epilepsy syndrome	0.000181	0.0197	CrCbGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CCL2—epilepsy syndrome	0.000181	0.000956	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GABBR1—epilepsy syndrome	0.00018	0.000955	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCR3—epilepsy syndrome	0.000177	0.000938	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TH—epilepsy syndrome	0.000177	0.000936	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	0.000176	0.000933	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—SOCS3—epilepsy syndrome	0.000175	0.000928	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HRH3—epilepsy syndrome	0.000173	0.000916	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—NPY—epilepsy syndrome	0.000173	0.000914	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	0.000172	0.000913	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCR5—epilepsy syndrome	0.000172	0.000909	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—OPRM1—epilepsy syndrome	0.00017	0.000902	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRM2—epilepsy syndrome	0.00017	0.0009	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	0.000169	0.000894	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR2A—epilepsy syndrome	0.000168	0.00089	CbGpPWpGaD
Amcinonide—Fluoxymesterone—NR3C1—epilepsy syndrome	0.000168	0.0182	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.000167	0.000882	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—OXT—epilepsy syndrome	0.000167	0.000882	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CRH—epilepsy syndrome	0.000167	0.000882	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—JUN—epilepsy syndrome	0.000166	0.000878	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—epilepsy syndrome	0.000165	0.000871	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	0.000164	0.00087	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—FOS—epilepsy syndrome	0.000163	0.000862	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—epilepsy syndrome	0.000163	0.000861	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCR3—epilepsy syndrome	0.000161	0.000852	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—AGT—epilepsy syndrome	0.000159	0.000844	CbGpPWpGaD
Amcinonide—Triamcinolone—NR3C1—epilepsy syndrome	0.000159	0.0173	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—NPY—epilepsy syndrome	0.000157	0.00083	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—MEF2C—epilepsy syndrome	0.000155	0.00082	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SSTR3—epilepsy syndrome	0.000154	0.000814	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000151	0.000801	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—OXT—epilepsy syndrome	0.000151	0.000801	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CRH—epilepsy syndrome	0.000151	0.000801	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCL3—epilepsy syndrome	0.000151	0.000801	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—SST—epilepsy syndrome	0.000151	0.000797	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000151	0.000797	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.00015	0.000797	CbGpPWpGaD
Amcinonide—Dexamethasone—NOS2—epilepsy syndrome	0.00015	0.0163	CrCbGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—SRC—epilepsy syndrome	0.000149	0.000788	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000147	0.000781	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCR9—epilepsy syndrome	0.000147	0.000781	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCR8—epilepsy syndrome	0.000147	0.000781	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NPY2R—epilepsy syndrome	0.000147	0.000781	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SSTR1—epilepsy syndrome	0.000147	0.000781	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000147	0.00078	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	0.000146	0.000775	CbGpPWpGaD
Amcinonide—Prednisone—NR3C1—epilepsy syndrome	0.000145	0.0157	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—GRM3—epilepsy syndrome	0.000145	0.000766	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRM4—epilepsy syndrome	0.000145	0.000766	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	0.000144	0.000763	CbGpPWpGaD
Amcinonide—Fluticasone Propionate—NR3C1—epilepsy syndrome	0.000143	0.0155	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—SSTR2—epilepsy syndrome	0.000142	0.000751	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DUSP4—epilepsy syndrome	0.000142	0.000751	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000142	0.00075	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000142	0.00075	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	0.000141	0.000746	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000139	0.000736	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000138	0.000733	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	0.000138	0.000732	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRM8—epilepsy syndrome	0.000137	0.000726	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PGF—epilepsy syndrome	0.000137	0.000726	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—SST—epilepsy syndrome	0.000137	0.000724	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCR2—epilepsy syndrome	0.000137	0.000724	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—WARS—epilepsy syndrome	0.000136	0.000722	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000136	0.000718	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—POMC—epilepsy syndrome	0.000134	0.000711	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000134	0.000709	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	0.000134	0.000708	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—AGT—epilepsy syndrome	0.000134	0.000708	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—epilepsy syndrome	0.000134	0.000707	CbGpPWpGaD
Amcinonide—Prednisolone—NR3C1—epilepsy syndrome	0.000133	0.0145	CrCbGaD
Amcinonide—Ciclesonide—CYP2D6—epilepsy syndrome	0.000133	0.0145	CrCbGaD
Amcinonide—NR3C1—AP-1 transcription factor network—JUN—epilepsy syndrome	0.000133	0.000703	CbGpPWpGaD
Amcinonide—Prednisone—CYP2C19—epilepsy syndrome	0.000132	0.0143	CrCbGaD
Amcinonide—ANXA1—GPCR ligand binding—CCL2—epilepsy syndrome	0.000131	0.000695	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—OPRD1—epilepsy syndrome	0.000131	0.000692	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GNAO1—epilepsy syndrome	0.000131	0.000692	CbGpPWpGaD
Amcinonide—Betamethasone—NR3C1—epilepsy syndrome	0.000131	0.0142	CrCbGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	0.000129	0.000685	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000129	0.000684	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP9—epilepsy syndrome	0.000129	0.000684	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000129	0.000681	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000129	0.000681	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	0.000128	0.000677	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	0.000127	0.00067	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CNR1—epilepsy syndrome	0.000126	0.000668	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000126	0.000666	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CHRM1—epilepsy syndrome	0.000125	0.000664	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PDYN—epilepsy syndrome	0.000125	0.000664	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRM1—epilepsy syndrome	0.000125	0.000664	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCR7—epilepsy syndrome	0.000125	0.000664	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR7—epilepsy syndrome	0.000123	0.000652	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IL6ST—epilepsy syndrome	0.000123	0.000651	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	0.000122	0.000645	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HBEGF—epilepsy syndrome	0.00012	0.000633	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—epilepsy syndrome	0.000118	0.000625	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000118	0.000624	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GFAP—epilepsy syndrome	0.000118	0.000624	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GAL—epilepsy syndrome	0.000118	0.000624	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT3—epilepsy syndrome	0.000117	0.000621	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—epilepsy syndrome	0.000117	0.000619	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRM5—epilepsy syndrome	0.000117	0.000617	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CHRM3—epilepsy syndrome	0.000117	0.000617	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CASP2—epilepsy syndrome	0.000117	0.000617	CbGpPWpGaD
Amcinonide—Fluticasone furoate—ABCB1—epilepsy syndrome	0.000114	0.0124	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—AVP—epilepsy syndrome	0.000114	0.000604	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000112	0.000592	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CHRM2—epilepsy syndrome	0.00011	0.00058	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CX3CL1—epilepsy syndrome	0.00011	0.00058	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—BDKRB1—epilepsy syndrome	0.00011	0.00058	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	0.000107	0.000568	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CDC42—epilepsy syndrome	0.000107	0.000567	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GABBR1—epilepsy syndrome	0.000107	0.000564	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	0.000105	0.000555	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AVP—epilepsy syndrome	0.000104	0.000549	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—QARS—epilepsy syndrome	0.000103	0.000547	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HRH3—epilepsy syndrome	0.000102	0.000541	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—OPRM1—epilepsy syndrome	0.000101	0.000533	CbGpPWpGaD
Amcinonide—Dexamethasone—ABCC2—epilepsy syndrome	9.96e-05	0.0108	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCR5—epilepsy syndrome	9.7e-05	0.000514	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCR3—epilepsy syndrome	9.5e-05	0.000503	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR2A—epilepsy syndrome	9.5e-05	0.000503	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ATP2A2—epilepsy syndrome	9.26e-05	0.00049	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NPY—epilepsy syndrome	9.26e-05	0.00049	CbGpPWpGaD
Amcinonide—Triamcinolone—PTGS2—epilepsy syndrome	9.05e-05	0.00984	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—AGT—epilepsy syndrome	9.01e-05	0.000477	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HSPB1—epilepsy syndrome	8.93e-05	0.000473	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCL3—epilepsy syndrome	8.93e-05	0.000473	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL2—epilepsy syndrome	8.93e-05	0.000473	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—OXT—epilepsy syndrome	8.93e-05	0.000473	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CRH—epilepsy syndrome	8.93e-05	0.000473	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCR5—epilepsy syndrome	8.81e-05	0.000467	CbGpPWpGaD
Amcinonide—Dexamethasone—ABCG2—epilepsy syndrome	8.81e-05	0.00957	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR2A—epilepsy syndrome	8.62e-05	0.000457	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.33e-05	0.000441	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TSC1—epilepsy syndrome	8.3e-05	0.00044	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTK2B—epilepsy syndrome	8.3e-05	0.00044	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EIF2B5—epilepsy syndrome	8.27e-05	0.000438	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AGT—epilepsy syndrome	8.18e-05	0.000433	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCR2—epilepsy syndrome	8.08e-05	0.000428	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SST—epilepsy syndrome	8.08e-05	0.000428	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NTRK2—epilepsy syndrome	8.08e-05	0.000428	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DUSP6—epilepsy syndrome	8.01e-05	0.000424	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADRA2A—epilepsy syndrome	7.91e-05	0.000419	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PLAT—epilepsy syndrome	7.87e-05	0.000417	CbGpPWpGaD
Amcinonide—Dexamethasone—NR3C1—epilepsy syndrome	7.6e-05	0.00826	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—BDKRB2—epilepsy syndrome	7.6e-05	0.000402	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL12—epilepsy syndrome	7.6e-05	0.000402	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—POMC—epilepsy syndrome	7.58e-05	0.000402	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PRKCB—epilepsy syndrome	7.56e-05	0.0004	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6ST—epilepsy syndrome	7.53e-05	0.000399	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—JUNB—epilepsy syndrome	7.53e-05	0.000399	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—TFAM—epilepsy syndrome	7.48e-05	0.000396	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CNR1—epilepsy syndrome	7.46e-05	0.000395	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JUNB—epilepsy syndrome	7.46e-05	0.000395	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PLCB1—epilepsy syndrome	7.43e-05	0.000393	CbGpPWpGaD
Amcinonide—Betamethasone—PTGS2—epilepsy syndrome	7.41e-05	0.00806	CrCbGaD
Amcinonide—Prednisone—ALB—epilepsy syndrome	7.31e-05	0.00795	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—HTR7—epilepsy syndrome	7.27e-05	0.000385	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	7.21e-05	0.000382	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	7.2e-05	0.000381	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HBEGF—epilepsy syndrome	7.06e-05	0.000374	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	6.99e-05	0.00037	CbGpPWpGaD
Amcinonide—Prednisone—ABCB1—epilepsy syndrome	6.98e-05	0.00759	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—AKT3—epilepsy syndrome	6.93e-05	0.000367	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP2C19—epilepsy syndrome	6.92e-05	0.00753	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—POMC—epilepsy syndrome	6.89e-05	0.000365	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADAM10—epilepsy syndrome	6.77e-05	0.000358	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCL2—epilepsy syndrome	6.74e-05	0.000357	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	6.58e-05	0.000349	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—epilepsy syndrome	6.52e-05	0.000345	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SNRPE—epilepsy syndrome	6.45e-05	0.000342	CbGpPWpGaD
Amcinonide—Prednisolone—ABCB1—epilepsy syndrome	6.43e-05	0.00699	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—S100B—epilepsy syndrome	6.4e-05	0.000339	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SOCS3—epilepsy syndrome	6.34e-05	0.000336	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CDC42—epilepsy syndrome	6.32e-05	0.000335	CbGpPWpGaD
Amcinonide—Betamethasone—ABCB1—epilepsy syndrome	6.3e-05	0.00685	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—AVP—epilepsy syndrome	6.12e-05	0.000324	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	6.11e-05	0.000323	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—epilepsy syndrome	6.06e-05	0.000321	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—VDR—epilepsy syndrome	5.97e-05	0.000316	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HES1—epilepsy syndrome	5.79e-05	0.000307	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FYN—epilepsy syndrome	5.63e-05	0.000298	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—H2AFX—epilepsy syndrome	5.61e-05	0.000297	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MEF2C—epilepsy syndrome	5.6e-05	0.000296	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.41e-05	0.000287	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NGF—epilepsy syndrome	5.35e-05	0.000283	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	5.24e-05	0.000277	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCR5—epilepsy syndrome	5.21e-05	0.000276	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP2D6—epilepsy syndrome	5.13e-05	0.00558	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—HTR2A—epilepsy syndrome	5.09e-05	0.00027	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TSC2—epilepsy syndrome	4.84e-05	0.000256	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AGT—epilepsy syndrome	4.83e-05	0.000256	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOE—epilepsy syndrome	4.74e-05	0.000251	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KDR—epilepsy syndrome	4.64e-05	0.000246	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EIF2S1—epilepsy syndrome	4.5e-05	0.000238	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRKCB—epilepsy syndrome	4.47e-05	0.000236	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6ST—epilepsy syndrome	4.45e-05	0.000236	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HSPB1—epilepsy syndrome	4.34e-05	0.00023	CbGpPWpGaD
Amcinonide—Dexamethasone—PTGS2—epilepsy syndrome	4.31e-05	0.00469	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—POMC—epilepsy syndrome	4.07e-05	0.000215	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCL2—epilepsy syndrome	3.98e-05	0.000211	CbGpPWpGaD
Amcinonide—Dexamethasone—ABCB1—epilepsy syndrome	3.67e-05	0.00398	CrCbGaD
Amcinonide—NR3C1—Gene Expression—JUNB—epilepsy syndrome	3.62e-05	0.000192	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGF2—epilepsy syndrome	3.6e-05	0.00019	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RELA—epilepsy syndrome	3.34e-05	0.000177	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MTOR—epilepsy syndrome	3.28e-05	0.000173	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.04e-05	0.000161	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CASP3—epilepsy syndrome	3.01e-05	0.000159	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JUN—epilepsy syndrome	2.93e-05	0.000155	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SIRT1—epilepsy syndrome	2.92e-05	0.000155	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—VDR—epilepsy syndrome	2.88e-05	0.000152	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP9—epilepsy syndrome	2.85e-05	0.000151	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT1—epilepsy syndrome	2.76e-05	0.000146	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—H2AFX—epilepsy syndrome	2.73e-05	0.000144	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—YWHAZ—epilepsy syndrome	2.63e-05	0.000139	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SRC—epilepsy syndrome	2.62e-05	0.000139	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—epilepsy syndrome	2.56e-05	0.000135	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT1—epilepsy syndrome	1.63e-05	8.64e-05	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AKT1—epilepsy syndrome	7.93e-06	4.2e-05	CbGpPWpGaD
